CD47 is overexpressed in various cancer types, including breast cancer, acute myeloid leukemia (AML) and chronic myeloid leukemia (CML), leiomyosarcoma, and head and neck squamous cell carcinoma [8–11]. This evidence concerns the gene CD47 and chronic myelogenous leukemia, BCR-ABL1 positive.